In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for February 2023
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Jonathan Licht named president, chief scientific officer at Van Andel Institute


















